Company research / CTSO
Cytosorbents Corp (CTSO)
- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
For the year ended 2025-12-31, Cytosorbents Corp reported revenue of $37.06M. Revenue grew 4.1% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $37.22M.
Key ratios (year ended 2025-12-31)
71.5%
Gross margin
-39.8%
Operating margin
-22.1%
Net margin
-138.9%
Return on year-end equity
4.1%
Revenue growth (YoY)
Beyond the statements
Follow the company.
Explore new filings, reported insider transactions and company relationships.